The percentage of PTEN and CDKN2A edits in the biopsy samples was nearly 10%, reflecting the presence of other non-tumor cells in the samples, including normal liver tissue adjacent to the tumors and tumor-infiltrating immune cells. The gene discussed is PTEN; the disease is neoplasm.